NTRK1 and cancer: In addition, as demonstrated by in silico studies, BaCf3 interacts with GLUT1 (Glucose transporter 1), which is overexpressed in many types of cancer, including lung cancer, and with the kinase domain of the MET receptor (MET Proto-Oncogene, Receptor Tyrosine Kinase), whose overexpression is detected in 25–50% of NSCLC patients.